| ||||||||||||||
|
|
|||||||||||||



Departments of
*Anesthesia and
Laboratory Medicine, Royal Alexandra Hospital; and Departments of
Anaesthesia and
§Pharmacology, University of Alberta Hospitals, Edmonton, Alberta, Canada
Address correspondence and reprint requests to Donald T. Jolly, MD, Department of Anesthesia, University of Alberta Hospitals, 3B2.32 WMHC, Edmonton, Alberta, Canada T6G 2C7. Address e-mail to dtjolly{at}compusmart.ab.ca
Propofol emulsion supports bacterial growth. Extrinsic contamination of propofol has been implicated as an etiological event in postsurgical infections. When added to propofol, local anesthetics (e.g., lidocaine) alleviate the pain associated with injecting it. Because local anesthetics have antimicrobial activity, we determined whether lidocaine would inhibit microbial growth by comparing the growth of four microorganisms in propofol and in mixtures of propofol and lidocaine. Known quanta of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans were inoculated into solutions of 1% propofol, 0.2% lidocaine in propofol, 0.5% lidocaine in propofol, 0.5% lidocaine in isotonic sodium chloride solution, and 0.9% isotonic sodium chloride solution. All microorganisms were taken from stock cultures and incubated for 24 h. Growth of microorganisms in each solution was compared by counting the number of colony-forming units grown from a subculture of the solution at 0, 3, 6, 12 and 24 h. Propofol supported the growth of E. coli and C. albicans. Propofol maintained static levels of S. aureus and was bactericidal toward P. aeruginosa. The addition of 0.2% and 0.5% lidocaine to propofol failed to prevent the growth of the studied microorganisms. The effect of 0.5% lidocaine in isotonic sodium chloride solution did not differ from the effects of isotonic sodium chloride solution alone. We conclude that lidocaine, when added to propofol in clinically acceptable concentrations, does not exhibit antimicrobial properties.
Implications: Local anesthetics such as lidocaine have antimicrobial activity. Propofol supports the growth of bacteria responsible for infection. Bacteria were added to propofol and propofol mixed with lidocaine. The addition of lidocaine to propofol in clinically relevant concentrations did not prevent the growth of bacteria. The addition of lidocaine to propofol cannot prevent infection from contaminated propofol.
This article has been cited by other articles:
![]() |
Y. Masaki, M. Tanaka, and T. Nishikawa Physicochemical Compatibility of Propofol-Lidocaine Mixture Anesth. Analg., December 1, 2003; 97(6): 1646 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Pollard, S. Makky, J. McFadzean, L. Ainsworth, S. M. Goobie, and C. J. Montgomery An admixture of 3 mg{middle dot}kg-1 of propofol and 3 mg{middle dot}kg-1 of thiopentone reduces pain on injection in pediatric anesthesia: [Un melange de 3 mg{middle dot}kg-1 de propofol et de 3 mg{middle dot}kg-1 de thiopental reduit la douleur a l'injection d'anesthesique chez les enfants] Can J Anesth, December 1, 2002; 49(10): 1064 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Lorenz, C. Kolbitsch, C. Lass-Florl, I. Gritznig, B. Vollert, W. Lingnau, P. L Moser, and A. Benzer Routine handling of propofol prevents contamination as effectively as does strict adherence to the manufacturer's recommendations: [Le maniement d'usage du propofol previent la contamination aussi effectivement que la stricte adhesion aux recommandations du fabricant] Can J Anesth, April 1, 2002; 49(4): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Cohen, R. S. Hannallah, and D. B. Goodale The Clinical and Biochemical Effects of Propofol Infusion With and Without EDTA for Maintenance Anesthesia in Healthy Children Undergoing Ambulatory Surgery Anesth. Analg., July 1, 2001; 93(1): 106 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Driver Jr., D. T. Jolly, I. Wachowski, J. Hrazdil, and J. C. Galbraith Conclusions Regarding Propofol/Lidocaine Admixture May Be Misleading • Response Anesth. Analg., November 1, 1999; 89(5): 1331 - 1331. [Full Text] [PDF] |
||||
|